IROBOT CORP (IRBT)
US4627261005 - Common Stock
Overall IRBT gets a fundamental rating of 1 out of 10. We evaluated IRBT against 67 industry peers in the Household Durables industry. Both the profitability and financial health of IRBT have multiple concerns. IRBT has a expensive valuation and it also scores bad on growth.
1. Profitability
1.1 Basic Checks
In the past year IRBT has reported negative net income.
In the past year IRBT has reported a negative cash flow from operations.
In multiple years IRBT reported negative net income over the last 5 years.
The reported operating cash flow has been mixed in the past 5 years: IRBT reported negative operating cash flow in multiple years.
1.2 Ratios
IRBT has a Return On Assets of -34.96%. This is amonst the worse of the industry: IRBT underperforms 92.31% of its industry peers.
IRBT's Return On Equity of -137.40% is on the low side compared to the rest of the industry. IRBT is outperformed by 92.31% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -34.96% | ||
| ROE | -137.4% | ||
| ROIC | N/A |
ROA(3y)-24.41%
ROA(5y)-10.32%
ROE(3y)-70.34%
ROE(5y)-35.93%
ROIC(3y)N/A
ROIC(5y)N/A
1.3 Margins
IRBT's Gross Margin of 20.95% is on the low side compared to the rest of the industry. IRBT is outperformed by 78.46% of its industry peers.
IRBT's Gross Margin has declined in the last couple of years.
The Profit Margin and Operating Margin are not available for IRBT so they could not be analyzed.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | N/A | ||
| PM (TTM) | N/A | ||
| GM | 20.95% |
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-22.24%
GM growth 5Y-15.4%
2. Health
2.1 Basic Checks
IRBT does not have a ROIC to compare to the WACC, probably because it is not profitable.
IRBT has more shares outstanding than it did 1 year ago.
IRBT has more shares outstanding than it did 5 years ago.
IRBT has a worse debt/assets ratio than last year.
2.2 Solvency
IRBT has an Altman-Z score of 0.70. This is a bad value and indicates that IRBT is not financially healthy and even has some risk of bankruptcy.
IRBT's Altman-Z score of 0.70 is on the low side compared to the rest of the industry. IRBT is outperformed by 84.62% of its industry peers.
IRBT has a Debt/Equity ratio of 1.16. This is a high value indicating a heavy dependency on external financing.
IRBT's Debt to Equity ratio of 1.16 is on the low side compared to the rest of the industry. IRBT is outperformed by 72.31% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 1.16 | ||
| Debt/FCF | N/A | ||
| Altman-Z | 0.7 |
ROIC/WACCN/A
WACC9.29%
2.3 Liquidity
IRBT has a Current Ratio of 1.53. This is a normal value and indicates that IRBT is financially healthy and should not expect problems in meeting its short term obligations.
Looking at the Current ratio, with a value of 1.53, IRBT is doing worse than 76.92% of the companies in the same industry.
A Quick Ratio of 1.08 indicates that IRBT should not have too much problems paying its short term obligations.
Looking at the Quick ratio, with a value of 1.08, IRBT is in the better half of the industry, outperforming 61.54% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 1.53 | ||
| Quick Ratio | 1.08 |
3. Growth
3.1 Past
The earnings per share for IRBT have decreased strongly by -27.23% in the last year.
Looking at the last year, IRBT shows a very negative growth in Revenue. The Revenue has decreased by -21.58% in the last year.
IRBT shows a decrease in Revenue. Measured over the last years, the Revenue has been decreasing by -4.01% yearly.
EPS 1Y (TTM)-27.23%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-38.03%
Revenue 1Y (TTM)-21.58%
Revenue growth 3Y-14.61%
Revenue growth 5Y-4.01%
Sales Q2Q%-29.68%
3.2 Future
The Earnings Per Share is expected to grow by 22.64% on average over the next years. This is a very strong growth
IRBT is expected to show a decrease in Revenue. In the coming years, the Revenue will decrease by -0.06% yearly.
EPS Next Y52.6%
EPS Next 2Y34.57%
EPS Next 3Y22.64%
EPS Next 5YN/A
Revenue Next Year-13.1%
Revenue Next 2Y-4.51%
Revenue Next 3Y-0.06%
Revenue Next 5YN/A
3.3 Evolution
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
4. Valuation
4.1 Price/Earnings Ratio
The Price/Earnings Ratio is negative for IRBT. In the last year negative earnings were reported.
Also next year IRBT is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | N/A |
4.2 Price Multiples
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | N/A | ||
| EV/EBITDA | N/A |
4.3 Compensation for Growth
IRBT's earnings are expected to grow with 22.64% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y34.57%
EPS Next 3Y22.64%
5. Dividend
5.1 Amount
IRBT does not give a dividend.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
IROBOT CORP
NASDAQ:IRBT (9/6/2024, 8:21:43 PM)
After market: 6.01 +0.04 (+0.67%)5.97
-0.43 (-6.72%)
Chartmill FA Rating
GICS SectorConsumer Discretionary
GICS IndustryGroupConsumer Durables & Apparel
GICS IndustryHousehold Durables
Earnings (Last)
Earnings (Next)
Inst Owners
Inst Owner Change
Ins Owners
Ins Owner Change
Market Cap171.70M
Analysts
Price Target
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
Dividend Growth(5Y)
DP
Div Incr Years
Div Non Decr Years
Ex-Date
Surprises & Revisions
EPS beat(2)
Avg EPS beat(2)
Min EPS beat(2)
Max EPS beat(2)
EPS beat(4)
Avg EPS beat(4)
Min EPS beat(4)
Max EPS beat(4)
EPS beat(8)
Avg EPS beat(8)
EPS beat(12)
Avg EPS beat(12)
EPS beat(16)
Avg EPS beat(16)
Revenue beat(2)
Avg Revenue beat(2)
Min Revenue beat(2)
Max Revenue beat(2)
Revenue beat(4)
Avg Revenue beat(4)
Min Revenue beat(4)
Max Revenue beat(4)
Revenue beat(8)
Avg Revenue beat(8)
Revenue beat(12)
Avg Revenue beat(12)
Revenue beat(16)
Avg Revenue beat(16)
PT rev (1m)
PT rev (3m)
EPS NQ rev (1m)
EPS NQ rev (3m)
EPS NY rev (1m)
EPS NY rev (3m)
Revenue NQ rev (1m)
Revenue NQ rev (3m)
Revenue NY rev (1m)
Revenue NY rev (3m)
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | N/A | ||
| P/S | |||
| P/FCF | |||
| P/OCF | |||
| P/B | |||
| P/tB | |||
| EV/EBITDA |
EPS(TTM)
EY
EPS(NY)
Fwd EY
FCF(TTM)
FCFY
OCF(TTM)
OCFY
SpS
BVpS
TBVpS
PEG (NY)N/A
PEG (5Y)N/A
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -34.96% | ||
| ROE | -137.4% | ||
| ROCE | |||
| ROIC | |||
| ROICexc | |||
| ROICexgc | |||
| OM | N/A | ||
| PM (TTM) | N/A | ||
| GM | 20.95% | ||
| FCFM |
ROA(3y)
ROA(5y)
ROE(3y)
ROE(5y)
ROIC(3y)
ROIC(5y)
ROICexc(3y)
ROICexc(5y)
ROICexgc(3y)
ROICexgc(5y)
ROCE(3y)
ROCE(5y)
ROICexcg growth 3Y
ROICexcg growth 5Y
ROICexc growth 3Y
ROICexc growth 5Y
OM growth 3Y
OM growth 5Y
PM growth 3Y
PM growth 5Y
GM growth 3Y
GM growth 5Y
F-Score
Asset Turnover1.38
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 1.16 | ||
| Debt/FCF | |||
| Debt/EBITDA | |||
| Cap/Depr | |||
| Cap/Sales | |||
| Interest Coverage | |||
| Cash Conversion | |||
| Profit Quality | |||
| Current Ratio | 1.53 | ||
| Quick Ratio | 1.08 | ||
| Altman-Z |
F-Score
WACC
ROIC/WACC
Cap/Depr(3y)
Cap/Depr(5y)
Cap/Sales(3y)
Cap/Sales(5y)
Profit Quality(3y)
Profit Quality(5y)
High Growth Momentum
Growth
EPS 1Y (TTM)-27.23%
EPS 3YN/A
EPS 5Y
EPS Q2Q%
EPS Next Y52.6%
EPS Next 2Y
EPS Next 3Y
EPS Next 5Y
Revenue 1Y (TTM)-21.58%
Revenue growth 3Y-14.61%
Revenue growth 5Y
Sales Q2Q%
Revenue Next Year
Revenue Next 2Y
Revenue Next 3Y
Revenue Next 5Y
EBIT growth 1Y
EBIT growth 3Y
EBIT growth 5Y
EBIT Next Year
EBIT Next 3Y
EBIT Next 5Y
FCF growth 1Y
FCF growth 3Y
FCF growth 5Y
OCF growth 1Y
OCF growth 3Y
OCF growth 5Y